Pamplona-based CDMO 3P Biopharmaceuticals (3P) has announced Keensight Capital as its new major investor...
Up To Date
Latest News
Molecular diagnostics expert Curetis NV has filed for US FDA clearance of Unyvero LRT to speed up diagnosis of...
Merck and the Broad Institute have signed an agreement on the granting of non-exclusive intellectual property...
Together with the EIB, five of the EU’s largest national promotional banks and institutions plan to invest...
Danish cancer antibody powerhouse Genmab plans to raise US$505m in its US IPO. The money will go towards its...
Dutch biopharma company AM-Pharma B.V. has secured €116m to bring its acute kidney injury treatment into Phase...